A group of state attorneys general has reached an agreement with Johnson & Johnson and three drug distributors this Wednesday to pay a penalty of $ 26 billion for fueling an opioid epidemic in the US, according to 'CNBC'.
The also manufacturer of the coronavirus vaccine must pay 5,000 million for minimizing the risk of addiction in the marketing of opioids. The company has a term of 18 years to pay the agreed sanction, contributing a maximum of 3,700 million in the first three years.
Meanwhile, the distributors McKesson, Cardinal Health and AmerisourceBergen have agreed to pay 21 billion by the massive diversion of addictive painkillers. All the companies involved deny the allegations.
The pact reached also requires the creation of a center to exchange information independent from the three distributors and to which state regulators have access on the destination of the drugs and their frequency. This tool aims to reduce the over-delivery of pills to communities.
This is another setback received by J&J this Wednesday, after learning that a study certifies that your vaccine is not effective against the Delta variant. This news has clouded the good results obtained by the drug manufacturer, which has achieved a 73% rise in profits in the second quarter.